{"SPADE_UN_26831": {"Sequence Information": {"Peptide Name": "Ranatuerin R2AW (1-22)-AMD", "Sequence": "GFMDTAKNVAKNVAATLLDKLK", "Sequence Length": 22, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "G3XHN9", "uniprotUrl": "http://www.uniprot.org/uniprot/G3XHN9", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Progressive Design of a Ranatuerin-2 Peptide from Amolops wuyiensis: Enhancement of Bioactivity and In Vivo Efficacy.", "Pubmed ID": "38275314", "Reference": "Antibiotics (Basel). 2024;13:5", "Author": "Yao A, Liu T, Cai Y, Zhou S, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38275314"}], "Mass": 2348.76, "PI": 9.53, "Net Charge": 2, "Hydrophobicity": 0.01, "Frequent Amino Acids": "AKL", "Absent Amino Acids": "CEHIOPQRSUWY", "Basic Residues": 4, "Acidic Residues": 2, "Hydrophobic Residues": 11, "Polar Residues": 11, "Positive Residues": 4, "Negative Residues": 2, "SPADE ID": "SPADE_UN_26831", "Similar Sequences": [{"SPADE_ID": "SPADE_N_01146", "Similarity": 1.0, "Sequence": "GFMDTAKNVAKNVAATLLDKLKCKITGGC"}, {"SPADE_ID": "SPADE_UN_26829", "Similarity": 1.0, "Sequence": "GFMDTAKNVAKNVAATLLDKLKSKITGGS"}, {"SPADE_ID": "SPADE_UN_26831", "Similarity": 1.0, "Sequence": "GFMDTAKNVAKNVAATLLDKLK"}], "Hemolytic Activity": "Horse erythrocytes:<10% Hemolysis=128 µM,Horse erythrocytes:18% Hemolysis=256 µM", "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=64µM),Staphylococcus aureus NCTC 10788(MBC=64µM),Escherichia coli ATCC 8739(MIC=128µM),Escherichia coli ATCC 8739(MBC=128µM),Staphylococcus aureus NCTC 12493(MIC=256µM),Staphylococcus aureus NCTC 12493(MBC=256µM),Klebsiella pneumoniae ATCC 43816(MIC=256µM),Klebsiella pneumoniae ATCC 43816(MBC=256µM),Enterococcus faecium NTCC 12697(MIC=256µM),Enterococcus faecium NTCC 12697(MBC=256µM),Pseudomonas aeruginosa ATCC 9027(MIC=512µM),Pseudomonas aeruginosa ATCC 9027(MBC=>512µM),Human lung adenocarcinoma NCI-H838(IC50=58.91µM),Human prostate adenocarcinoma PC-3(IC50=194.3µM),Human glioblastoma U251-MG(IC50=515.8µM),Human breast adenocarcinoma MCF-7(IC50=373.6µM),Human colon adenocarcinoma HCT 116(IC50=609µM)"}}}